| scholarly article | Q13442814 |
| P50 | author | Stephen L. Hauser | Q7609730 |
| Michael R Wilson | Q56434547 | ||
| Hans-Christian von Büdingen | Q73517832 | ||
| Antje Bischof | Q85643745 | ||
| Stanislas Demuth | Q89476296 | ||
| Ariele L Greenfield | Q102220100 | ||
| Erica L Eggers | Q114403604 | ||
| Aya Abounasr | Q125288548 | ||
| Natalie S Pierson | Q125289085 | ||
| P2093 | author name string | Hao Wu | |
| Carolyn J Bevan | |||
| Bruce Ac Cree | |||
| Roland G Henry | |||
| Brady A Michel | |||
| Sheng-Zhi Wang | |||
| Elizabeth Leitner | |||
| Max Kazer | |||
| P2860 | cites work | Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis | Q21144285 |
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| B-cell depletion with rituximab in relapsing-remitting multiple sclerosis | Q28268626 | ||
| A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis | Q29616119 | ||
| Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial | Q34229618 | ||
| Performance comparison of benchtop high-throughput sequencing platforms | Q34241334 | ||
| Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. | Q34251673 | ||
| Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein | Q34293468 | ||
| The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations | Q34459965 | ||
| Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis | Q34472457 | ||
| Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation. | Q35077861 | ||
| Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions | Q35090021 | ||
| B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status. | Q35286950 | ||
| B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes | Q35298764 | ||
| Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients | Q35585366 | ||
| The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research | Q35883319 | ||
| B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue. | Q36220292 | ||
| B cell exchange across the blood-brain barrier in multiple sclerosis | Q36498036 | ||
| Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis | Q36639659 | ||
| Specific peripheral B cell tolerance defects in patients with multiple sclerosis | Q36890946 | ||
| Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. | Q37285430 | ||
| Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. | Q37385073 | ||
| Onset of secondary progressive MS after long-term rituximab therapy - a case report. | Q37572960 | ||
| In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. | Q37652977 | ||
| Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis | Q40400256 | ||
| Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis | Q40400262 | ||
| Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire | Q41505077 | ||
| B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions | Q41697260 | ||
| Immunological markers of optimal response to natalizumab in multiple sclerosis. | Q43731725 | ||
| Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation | Q44681284 | ||
| Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial | Q45119459 | ||
| Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy | Q45405778 | ||
| Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study | Q45890653 | ||
| The risk of relapses in multiple sclerosis during systemic infections | Q46129279 | ||
| Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis | Q47309556 | ||
| Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. | Q47357498 | ||
| MiXCR: software for comprehensive adaptive immunity profiling. | Q48193977 | ||
| Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands". | Q48412765 | ||
| Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. | Q48427388 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis | Q48949365 | ||
| Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis | Q48949792 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. | Q54180855 | ||
| Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid | Q59543689 | ||
| Lymphocyte Subpopulations in the Cerebrospinal Fluid and Peripheral Blood in Patients with Multiple Sclerosis | Q66881982 | ||
| Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts | Q81588164 | ||
| Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients | Q82276225 | ||
| Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study | Q85291118 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 22 | |
| P577 | publication date | 2017-11-16 | |
| P1433 | published in | JCI insight | Q27727187 |
| P1476 | title | Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients | |
| P478 | volume | 2 |
| Q89943881 | A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells |
| Q88161098 | Antibody repertoire analysis in polygenic autoimmune diseases |
| Q46583404 | B Cell Therapy for Multiple Sclerosis: Entering an Era. |
| Q104479846 | B cell depletion therapies in autoimmune disease: advances and mechanistic insights |
| Q91236273 | B cells in autoimmune and neurodegenerative central nervous system diseases |
| Q92712543 | Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis |
| Q52650355 | Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells. |
| Q52577393 | Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis. |
| Q92339537 | Induction of brain-infiltrating T-bet-expressing B cells in multiple sclerosis |
| Q92642889 | Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis |
| Q64066412 | Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis |
| Q91868748 | Plasma Cells, the Next Generation: Beyond Antibody Secretion |
| Q91728778 | Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire |
| Q89171079 | Reassessing B cell contributions in multiple sclerosis |
| Q57825775 | Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis |
| Q92302527 | The role of B cells in multiple sclerosis: Current and future therapies |
| Q96306924 | [Ocrelizumab for treatment of multiple sclerosis] |
Search more.